ATE378328T1 - Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung - Google Patents

Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Info

Publication number
ATE378328T1
ATE378328T1 AT02712114T AT02712114T ATE378328T1 AT E378328 T1 ATE378328 T1 AT E378328T1 AT 02712114 T AT02712114 T AT 02712114T AT 02712114 T AT02712114 T AT 02712114T AT E378328 T1 ATE378328 T1 AT E378328T1
Authority
AT
Austria
Prior art keywords
pyrrolo
prodrugs
indole
tumor treatment
quinoline derivatives
Prior art date
Application number
AT02712114T
Other languages
English (en)
Inventor
Mark Searcey
L Patterson
Original Assignee
Univ London Pharmacy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Pharmacy filed Critical Univ London Pharmacy
Application granted granted Critical
Publication of ATE378328T1 publication Critical patent/ATE378328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
AT02712114T 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung ATE378328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01301636 2001-02-22

Publications (1)

Publication Number Publication Date
ATE378328T1 true ATE378328T1 (de) 2007-11-15

Family

ID=8181737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02712114T ATE378328T1 (de) 2001-02-22 2002-02-22 Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung

Country Status (7)

Country Link
US (1) US7626026B2 (de)
EP (1) EP1409480B1 (de)
JP (1) JP2004529887A (de)
AT (1) ATE378328T1 (de)
DE (1) DE60223544T2 (de)
ES (1) ES2299560T3 (de)
WO (1) WO2002068412A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4862120B2 (ja) * 2001-02-22 2012-01-25 ユニヴァーシティ オブ ブラッドフォード 腫瘍治療のためのプロドラッグとしてのベンズ−インドールおよびベンゾ−キノリン誘導体
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
GB0505644D0 (en) 2005-03-18 2005-04-27 Univ London Pharmacy Analogues of the azinomycins as anti-tumour agents and as prodrugs
JP5079818B2 (ja) * 2006-12-22 2012-11-21 メルク・シャープ・アンド・ドーム・コーポレーション Hcvおよび関連するウイルス疾患の治療または予防のための4,5−環インドール誘導体
JP5055377B2 (ja) 2006-12-22 2012-10-24 シェーリング コーポレイション [5,6−環]環形成インドール誘導体およびその使用方法
KR20090106539A (ko) * 2006-12-22 2009-10-09 쉐링 코포레이션 Hcv 및 관련 바이러스 감염을 치료 또는 예방하기 위한 4,5-환 환상 인돌 유도체
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
WO2009032124A1 (en) 2007-08-29 2009-03-12 Schering Corporation Substituted indole derivatives and methods of use thereof
RU2010111550A (ru) 2007-08-29 2011-10-10 Шеринг Корпорейшн (US) 2,3-замещенные индольные производные для лечения вирусных инфекций
EP2195317B1 (de) 2007-08-29 2012-01-18 Schering Corporation 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
US8765757B2 (en) 2007-11-16 2014-07-01 Merck Sharp & Dohme Corp. 3-heterocyclic substituted indole derivatives and methods of use thereof
CN102317285A (zh) 2007-11-16 2012-01-11 先灵公司 3-氨基磺酰基取代的吲哚衍生物及其使用方法
JP5580814B2 (ja) 2008-06-13 2014-08-27 メルク・シャープ・アンド・ドーム・コーポレーション 3環式インドール誘導体およびその使用方法
HUE035798T2 (en) 2008-11-03 2018-05-28 Syntarga Bv CC-1065 analogues and conjugates
NO3056203T3 (de) 2010-04-21 2018-05-12
US8496218B2 (en) * 2011-06-08 2013-07-30 Alcon Research, Ltd. Display monitor guide
TR201810856T4 (tr) 2014-01-10 2018-08-27 Synthon Biopharmaceuticals Bv CYS'le bağlı antikor-ilaç konjugatlarını saflaştırmak için usul.
GB202300668D0 (en) * 2023-01-17 2023-03-01 Univ Bradford Cancer treating compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
EP0244120A3 (de) 1986-04-16 1989-07-12 Courtaulds Plc Element aus Verbundwerkstoff
FI85403C (fi) 1989-12-22 1992-04-10 Neste Oy Foerfarande foer framstaellning av en plastkompositbalk eller -pelare med staolfoerstaerkningen.
EP0563475B1 (de) 1992-03-25 2000-05-31 Immunogen Inc Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
FR2700805B1 (fr) 1993-01-27 1995-04-07 Ind Entreprise Procédé de renforcement d'une poutre détériorée, et poutre ainsi obtenue.
US5448869A (en) 1994-02-17 1995-09-12 Marvin Lumber And Cedar Co. Composite framing member and window or door assembly incorporating a composite framing member
US5720143A (en) 1994-03-01 1998-02-24 The United States Of America As Represented By The Secretary Of Agriculture Localized notch reinforcement for wooden beams
US5501054A (en) 1994-03-01 1996-03-26 The United States Of America As Represented By The Secretary Of Agriculture Bolted wood connections
US5679432A (en) 1994-05-09 1997-10-21 Benchmark Foam, Inc. Multi-layer laminate structure
US5688426A (en) 1995-06-07 1997-11-18 The Boeing Company Hybrid metal webbed composite beam
US5657595A (en) 1995-06-29 1997-08-19 Hexcel-Fyfe Co., L.L.C. Fabric reinforced beam and column connections
GB9519490D0 (en) 1995-09-25 1995-11-29 Melvin William T Use of a cytochrome P450 enzyme in tumour cells as a marker and target
US5985908A (en) 1996-03-08 1999-11-16 The Scripps Research Institute MCBI analogs of CC-1065 and the duocarmycins
US5843937A (en) * 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
CA2255703A1 (en) * 1996-05-31 1997-12-04 Dale L. Boger Analogs of cc-1065 and the duocarmycins
US5794402A (en) 1996-09-30 1998-08-18 Martin Marietta Materials, Inc. Modular polymer matrix composite support structure and methods of constructing same
WO1998052925A1 (en) * 1997-05-22 1998-11-26 The Scripps Research Institute Analogs of duocarmycin and cc-1065
DE69918950T2 (de) 1998-02-06 2005-07-28 De Montfort University Durch hydroxylierung aktivierte medikamentvorstufen

Also Published As

Publication number Publication date
ES2299560T3 (es) 2008-06-01
JP2004529887A (ja) 2004-09-30
DE60223544D1 (de) 2007-12-27
EP1409480B1 (de) 2007-11-14
US20040157873A1 (en) 2004-08-12
DE60223544T2 (de) 2008-09-25
US7626026B2 (en) 2009-12-01
WO2002068412A1 (en) 2002-09-06
EP1409480A1 (de) 2004-04-21

Similar Documents

Publication Publication Date Title
DE60223544D1 (de) Pyrrolo-indol- und pyrrolo-chinolin-derivate als prodrugs zur tumorbehandlung
ATE327750T1 (de) Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
DE60220057D1 (de) Indoline und tetrahydro-chinoline als prodrugs zur tumorbehandlung
PT2420234E (pt) 1h-benzimidazole-4-carboxamidas substituídas com um carbono quaternário na posição 2 como inibidores de parp para uso no tratamento do cancro
EP4272748A3 (de) Antisense-oligonukleotide zur induzierung von exon-skipping und verfahren zur verwendung davon
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
SG164368A1 (en) Treatment of cancer
MX2009004888A (es) Inhibidores del virus de la hepatitis c.
NZ580226A (en) Dimer compounds as inhibitors of iap
MX2009006864A (es) Inhibidores novedosos de c jun-n-terminal cinasas.
EP1604010A4 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR siRNA-HEMMUNG VON ICAM-1
PT1902037E (pt) 2,4-diamino-pirimidinas como inibidores de aurora
EP3173415A3 (de) Aktivatoren der menschlichen pyruvatkinase
WO2010000364A8 (de) Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate
MX2007003470A (es) Compuestos de carbonilo los cuales pueden utilizarse como inhibidores del factor de coagulacion xa.
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
WO2005086860A3 (en) Methods for generating insulin-producing cells
ATE432922T1 (de) Substituierte 5-carboxyamidpyrazoles und ä1,2, 4ütriazole als viruzide
WO2008152306A3 (fr) Nouveaux substrats de peptidase
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2006035244A3 (en) Ecteinascidin compounds as anti -inflammatory agents
WO2006071966A3 (en) Rapamycin compounds in the treatment of neurofibromatosis type 1
TW200637806A (en) 2-alkylcycloalk(en)ylcarboxamides
MX2007006090A (es) 2-metilen-19-nor-(20r)-1a-hidroxi-bishomopregnacalciferol.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties